Under pathological conditions, Liang et al. showed that aberrant levels of S1P occurs through up-regulation of SphK1 in cancer cells, which contributes to inflammation and the progression of colon cancer [17]. This evidence concerns the gene SPHK1 and malignant colon neoplasm.